QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Eledon Pharmaceuticals (ELDN) Short Interest Ratio & Short Volume

$1.80
-0.04 (-2.17%)
(As of 02/29/2024 ET)

Eledon Pharmaceuticals Short Interest Data

Current Short Volume
53,200 shares
Previous Short Volume
60,300 shares
Change Vs. Previous Month
-11.77%
Dollar Volume Sold Short
$97,356.00
Short Interest Ratio / Days to Cover
0.8
Last Record Date
February 15, 2024
Outstanding Shares
24,198,000 shares
Percentage of Shares Shorted
0.22%
Today's Trading Volume
102,880 shares
Average Trading Volume
59,760 shares
Today's Volume Vs. Average
172%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Eledon Pharmaceuticals ?

Sign up to receive the latest short interest report for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ELDN Short Interest Over Time

ELDN Days to Cover Over Time

ELDN Percentage of Float Shorted Over Time


Eledon Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202453,200 shares $97,356.00 -11.8%N/A0.8 $1.83
1/31/202460,300 shares $107,334.00 -15.6%N/A0.8 $1.78
1/15/202471,400 shares $123,529.14 +37.3%N/A0.8 $1.73
12/31/202352,000 shares $93,600.00 -20.4%N/A0.6 $1.80
12/15/202365,300 shares $99,256.00 +147.4%N/A0.7 $1.52
11/30/202326,400 shares $30,360.00 -59.9%N/A0.3 $1.15
11/15/202365,900 shares $82,375.00 +25.8%N/A0.7 $1.25
10/31/202352,400 shares $81,744.00 +5.2%N/A0.6 $1.56
10/15/202349,800 shares $73,704.00 -20.1%N/A0.7 $1.48
9/30/202362,300 shares $85,351.00 +92.3%N/A0.9 $1.37
9/15/202332,400 shares $40,500.00 +18.7%N/A0.6 $1.25
8/31/202327,300 shares $41,496.00 -34.4%N/A0.5 $1.52
8/15/202341,600 shares $50,752.00 +1.2%N/A0.5 $1.22
7/31/202341,100 shares $56,718.00 +18.1%N/A0.3 $1.38
7/15/202334,800 shares $50,112.00 -4.1%N/A0.2 $1.44
6/30/202336,300 shares $49,731.00 -85.1%N/A0.2 $1.37
6/15/2023244,200 shares $402,930.00 +383.6%2.0%1.3 $1.65
5/31/202350,500 shares $106,050.00 +136.0%0.4%0.3 $2.10
5/15/202321,400 shares $49,648.00 -62.6%0.2%0.1 $2.32
4/30/202357,200 shares $120,120.00 +276.3%0.4%0.5 $2.10
4/15/202315,200 shares $37,088.00 -47.0%0.1%0.6 $2.44
3/31/202328,700 shares $67,732.00 +64.9%0.2%1.1 $2.36
3/15/202317,400 shares $34,974.00 +4.2%0.1%0.8 $2.01
2/28/202316,700 shares $39,412.00 -9.2%0.1%1 $2.36
2/15/202318,400 shares $49,864.00 +8.2%0.1%1.2 $2.71
1/31/202317,000 shares $56,440.00 +6.3%0.1%1.1 $3.32
1/15/202316,000 shares $45,561.60 +11.9%0.1%1.1 $2.85
12/30/202214,300 shares $32,604.00 +19.2%0.1%0.7 $2.28
12/15/202212,000 shares $28,972.80 -39.7%0.1%0.6 $2.41
11/30/202219,900 shares $48,556.00 -20.1%0.1%1 $2.44
11/15/202224,900 shares $65,736.00 +69.4%0.2%1.1 $2.64
10/31/202214,700 shares $35,427.00 -2.0%0.1%0.6 $2.41
10/15/202215,000 shares $37,992.00 -29.9%0.1%0.6 $2.53
9/30/202221,400 shares $59,064.00 -4.9%0.2%0.7 $2.76
9/15/202222,500 shares $76,500.00 -17.6%0.2%0.7 $3.40
8/31/202227,300 shares $102,375.00 +31.3%0.2%0.5 $3.75
8/15/202220,800 shares $73,632.00 +181.1%0.2%0.3 $3.54
7/31/20227,400 shares $22,274.00 -10.8%0.1%0.1 $3.01
7/15/20228,300 shares $24,900.00 +31.8%0.1%0.1 $3.00
6/30/20226,300 shares $15,372.00 -84.9%0.1%0.1 $2.44













ELDN Short Interest - Frequently Asked Questions

What is Eledon Pharmaceuticals' current short interest?

Short interest is the volume of Eledon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 53,200 shares of ELDN short. Learn More on Eledon Pharmaceuticals' current short interest.

What is a good short interest ratio for Eledon Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELDN shares currently have a short interest ratio of 1.0. Learn More on Eledon Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Eledon Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eledon Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Eledon Pharmaceuticals' short interest increasing or decreasing?

Eledon Pharmaceuticals saw a decrease in short interest in February. As of February 15th, there was short interest totaling 53,200 shares, a decrease of 11.8% from the previous total of 60,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Eledon Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Eledon Pharmaceuticals: NextCure, Inc. (0.60%), Acurx Pharmaceuticals, Inc. (2.65%), Bolt Biotherapeutics, Inc. (6.77%), BeyondSpring Inc. (7.89%), Cellectar Biosciences, Inc. (20.08%), Lantern Pharma Inc. (0.76%), ImmunoPrecise Antibodies Ltd. (0.24%), Daré Bioscience, Inc. (0.51%), ProMIS Neurosciences, Inc. (0.28%), Rockwell Medical, Inc. (2.48%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Eledon Pharmaceuticals stock?

Short selling ELDN is an investing strategy that aims to generate trading profit from Eledon Pharmaceuticals as its price is falling. ELDN shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eledon Pharmaceuticals?

A short squeeze for Eledon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELDN, which in turn drives the price of the stock up even further.

How often is Eledon Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELDN, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ELDN) was last updated on 2/29/2024 by MarketBeat.com Staff